Paul Chang Lee

Array ( [id] => 4207963 [patent_doc_number] => 06028059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Methods for modulating protein function in cells using intracellular antibody homologues' [patent_app_type] => 1 [patent_app_number] => 8/668706 [patent_app_country] => US [patent_app_date] => 1996-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 16 [patent_no_of_words] => 19437 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028059.pdf [firstpage_image] =>[orig_patent_app_number] => 668706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793045 [patent_doc_number] => 05780447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Recombinant adeno-associated viral vectors' [patent_app_type] => 1 [patent_app_number] => 8/663947 [patent_app_country] => US [patent_app_date] => 1996-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 12677 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780447.pdf [firstpage_image] =>[orig_patent_app_number] => 663947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986395 [patent_doc_number] => 05985243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Mouse model for Helicobacter pylori infection' [patent_app_type] => 1 [patent_app_number] => 8/649604 [patent_app_country] => US [patent_app_date] => 1996-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4505 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985243.pdf [firstpage_image] =>[orig_patent_app_number] => 649604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3826967 [patent_doc_number] => 05783566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Method for increasing or decreasing transfection efficiency' [patent_app_type] => 1 [patent_app_number] => 8/644095 [patent_app_country] => US [patent_app_date] => 1996-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13788 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783566.pdf [firstpage_image] =>[orig_patent_app_number] => 644095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772630 [patent_doc_number] => 05807838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Oligonucleotide modulation of multidrug resistance-associated protein' [patent_app_type] => 1 [patent_app_number] => 8/628731 [patent_app_country] => US [patent_app_date] => 1996-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6391 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807838.pdf [firstpage_image] =>[orig_patent_app_number] => 628731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812536 [patent_doc_number] => 05789230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Endosomolytically active particles' [patent_app_type] => 1 [patent_app_number] => 8/628665 [patent_app_country] => US [patent_app_date] => 1996-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9938 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789230.pdf [firstpage_image] =>[orig_patent_app_number] => 628665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232540 [patent_doc_number] => 06074836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Method of marking eukaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/602791 [patent_app_country] => US [patent_app_date] => 1996-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10099 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074836.pdf [firstpage_image] =>[orig_patent_app_number] => 602791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3990204 [patent_doc_number] => 05891718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Tetracycline inducible/repressible systems' [patent_app_type] => 1 [patent_app_number] => 8/622956 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 12060 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891718.pdf [firstpage_image] =>[orig_patent_app_number] => 622956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847504 [patent_doc_number] => 05766882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'recombinant poxviruses with foreign DNA in essential regions' [patent_app_type] => 1 [patent_app_number] => 8/616133 [patent_app_country] => US [patent_app_date] => 1996-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10742 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766882.pdf [firstpage_image] =>[orig_patent_app_number] => 616133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4053269 [patent_doc_number] => 05969215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method of plant tissue culture and regeneration' [patent_app_type] => 1 [patent_app_number] => 8/615216 [patent_app_country] => US [patent_app_date] => 1996-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6633 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969215.pdf [firstpage_image] =>[orig_patent_app_number] => 615216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745269 [patent_doc_number] => 05801233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Nucleic acid compositions encoding acetyl-coa carboxylase and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/611107 [patent_app_country] => US [patent_app_date] => 1996-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 41441 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801233.pdf [firstpage_image] =>[orig_patent_app_number] => 611107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943527 [patent_doc_number] => 05990090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Methods and compositions for treatment of diseases' [patent_app_type] => 1 [patent_app_number] => 8/607519 [patent_app_country] => US [patent_app_date] => 1996-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 22 [patent_no_of_words] => 5617 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990090.pdf [firstpage_image] =>[orig_patent_app_number] => 607519 [rel_patent_id] =>[rel_patent_doc_number] =>)